Wheeler Bio opens downtown OKC facility

A biotech startup marked the grand opening of its state-of-the-art drug substance Current Good Manufacturing Practice facility Thursday with a ribbon-cutting ceremony downtown.
Wheeler Bio, a contract development and manufacturing organization, or CDMO, for next-generation protein therapeutics, will begin production for customers next month in the 35,000-square-foot Ziggurat building in downtown Oklahoma City.

CEO Jesse McCool launched the company close to three years ago with the intention of filling a gap that exists between drug discovery and scale-up manufacturing of small-molecule biologic drugs used for cancer and autoimmune conditions. McCool reflected Thursday on the company milestone.

Read more at The Journal Record


Related Posts